These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7915136)

  • 1. Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.
    Penner SB; Smyth DD
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():43-8. PubMed ID: 7915136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?
    Smyth DD; Penner SB
    J Auton Nerv Syst; 1998 Oct; 72(2-3):155-62. PubMed ID: 9851564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine.
    Penner SB; Smyth DD
    Br J Pharmacol; 1994 Aug; 112(4):1089-94. PubMed ID: 7952868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine.
    Penner SB; Smyth DD
    Br J Pharmacol; 1995 Nov; 116(6):2631-6. PubMed ID: 8590981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1996 Jan; 117(1):29-34. PubMed ID: 8825339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal imidazoline preferring sites and solute excretion in the rat.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1993 Apr; 108(4):870-5. PubMed ID: 8097955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and central imidazoline receptor-mediated natriuresis in the rat.
    Smyth DD; Penner SB
    Ann N Y Acad Sci; 1999 Jun; 881():344-57. PubMed ID: 10415934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
    de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
    Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent absence of direct renal effect of imidazoline receptor agonists.
    Smyth DD; Pirnat D; Forzley B; Penner SB
    Ann N Y Acad Sci; 2003 Dec; 1009():288-95. PubMed ID: 15028602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide is involved in renal actions of moxonidine.
    Mukaddam-Daher S; Gutkowska J
    Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the natriuretic action of the imidazoline receptor agonist moxonidine by indometacin in the rat.
    Darkwa FK; Smyth DD
    Pharmacology; 1995 Dec; 51(6):347-55. PubMed ID: 8966191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central moxonidine on water and NaCl intake.
    Menani JV; Sato MA; Haikel L; Vieira AA; de Andrade CA; da Silva DC; Renzi A; De Luca LA
    Brain Res Bull; 1999 Jul; 49(4):273-9. PubMed ID: 10424847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation altered the hemodynamic and renal effects following intracerebroventricular administration of the I1-imidazoline receptor agonist, rilmenidine, in pentobarbital anaesthetized rats.
    Penner SB; Smyth DD
    Neurochem Int; 1997 Jan; 30(1):55-62. PubMed ID: 9116588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of forebrain imidazoline and alpha(2)-adrenergic receptors in the antidipsogenic response to moxonidine.
    Andrade CA; Oliveira LB; Martinez G; Silva DC; De Luca LA; Menani JV
    Ann N Y Acad Sci; 2003 Dec; 1009():262-4. PubMed ID: 15028596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and blood pressure effects of moxonidine and clonidine in spontaneously hypertensive rats.
    Hohage H; Hess K; Jahl C; Greven J; Schlatter E
    Clin Nephrol; 1997 Dec; 48(6):346-52. PubMed ID: 9438092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.